about
Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometryMeasurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperClinical use of PET/CT in thyroid cancer diagnosis and managementThe path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management.Nabothian cyst associated with high false-positive incidence of iodine-131 uptake in whole-body scans after treatment for differentiated thyroid cancer.The role of nuclear medicine in differentiated thyroid cancer.Imaging for the diagnosis of thyroid cancer.Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature.Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy.Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.Indications for thyroid cancer surgery in elderly patients.
P2860
Q33370510-652CC22F-4DAA-4770-8D0F-1564955CA50DQ33594636-9B9E5B78-3169-4E70-8A8D-62408E9077C3Q33825202-6FAAAE8E-632E-46DB-B91C-72A943A5C634Q34991946-BA43847D-95D5-48A9-BDB1-DD1227FE1646Q35048047-0F3FA21A-322B-4F1C-AADF-7BB9E306FA4BQ36337288-E10FB674-99AF-4715-8E1B-4CEBB667FA02Q37208856-59E0E53E-6D42-40FF-A826-676B89D6594BQ37273131-1D6505DF-7D9F-4642-AB35-BCEF2A480579Q38027799-2E9AAAB7-BB65-4203-AF9A-C18A73757BDDQ38089062-AB0AA6C8-F3A9-46AD-BE4B-2879A09E2DF5Q38578860-655290EA-D1B0-4876-A868-10AD9DDFAA2CQ42094673-BCB6B945-3951-485E-9950-E5468C26B72FQ44983474-4C09819F-04B7-40C7-A164-AE53653558F3Q46025589-5B10B5F4-CE9D-440D-851C-D7CE8522CF06Q47315266-3AD44540-A976-4FBF-B839-04BFD3054CCFQ49110822-34C28541-0405-45CC-9D69-F6AEF5A9DE26
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Follow-up of differentiated thyroid cancer.
@ast
Follow-up of differentiated thyroid cancer.
@en
Follow-up of differentiated thyroid cancer.
@nl
type
label
Follow-up of differentiated thyroid cancer.
@ast
Follow-up of differentiated thyroid cancer.
@en
Follow-up of differentiated thyroid cancer.
@nl
prefLabel
Follow-up of differentiated thyroid cancer.
@ast
Follow-up of differentiated thyroid cancer.
@en
Follow-up of differentiated thyroid cancer.
@nl
P1476
Follow-up of differentiated thyroid cancer.
@en
P2093
Furio Pacini
P2888
P304
P356
10.1007/S00259-002-0847-9
P478
29 Suppl 2
P577
2002-06-13T00:00:00Z